200 related articles for article (PubMed ID: 30843539)
1. The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.
Baljon JJ; Dandy A; Wang-Bishop L; Wehbe M; Jacobson ME; Wilson JT
Biomater Sci; 2019 Apr; 7(5):1888-1897. PubMed ID: 30843539
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery.
Hendershot J; Smith AE; Werfel TA
J Vis Exp; 2019 May; (147):. PubMed ID: 31107463
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.
Evans BC; Nelson CE; Yu SS; Beavers KR; Kim AJ; Li H; Nelson HM; Giorgio TD; Duvall CL
J Vis Exp; 2013 Mar; (73):e50166. PubMed ID: 23524982
[TBL] [Abstract][Full Text] [Related]
4. Controlling endosomal escape using nanoparticle composition: current progress and future perspectives.
Cupic KI; Rennick JJ; Johnston AP; Such GK
Nanomedicine (Lond); 2019 Jan; 14(2):215-223. PubMed ID: 30511881
[TBL] [Abstract][Full Text] [Related]
5. Distinct changes in endosomal composition promote NLRP3 inflammasome activation.
Zhang Z; Venditti R; Ran L; Liu Z; Vivot K; Schürmann A; Bonifacino JS; De Matteis MA; Ricci R
Nat Immunol; 2023 Jan; 24(1):30-41. PubMed ID: 36443515
[TBL] [Abstract][Full Text] [Related]
6. The APPL1-Rab5 axis restricts NLRP3 inflammasome activation through early endosomal-dependent mitophagy in macrophages.
Wu KKL; Long K; Lin H; Siu PMF; Hoo RLC; Ye D; Xu A; Cheng KKY
Nat Commun; 2021 Nov; 12(1):6637. PubMed ID: 34789781
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Ubiquitination-A New Approach to Target NLRP3 Inflammasome Activation.
Akther M; Haque ME; Park J; Kang TB; Lee KH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445484
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
9. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery.
Yu H; Zou Y; Wang Y; Huang X; Huang G; Sumer BD; Boothman DA; Gao J
ACS Nano; 2011 Nov; 5(11):9246-55. PubMed ID: 22011045
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.
Katsnelson MA; Lozada-Soto KM; Russo HM; Miller BA; Dubyak GR
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C83-C100. PubMed ID: 27170638
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis.
Chen Y; Li X; Boini KM; Pitzer AL; Gulbins E; Zhang Y; Li PL
Biochim Biophys Acta; 2015 Feb; 1853(2):396-408. PubMed ID: 25450976
[TBL] [Abstract][Full Text] [Related]
12. Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.
Kilchrist KV; Dimobi SC; Jackson MA; Evans BC; Werfel TA; Dailing EA; Bedingfield SK; Kelly IB; Duvall CL
ACS Nano; 2019 Feb; 13(2):1136-1152. PubMed ID: 30629431
[TBL] [Abstract][Full Text] [Related]
13. Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation.
Flanary S; Hoffman AS; Stayton PS
Bioconjug Chem; 2009 Feb; 20(2):241-8. PubMed ID: 19125614
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal monitoring endocytic and cytosolic pH gradients with endosomal escaping pH-responsive micellar nanocarriers.
Hu J; Liu G; Wang C; Liu T; Zhang G; Liu S
Biomacromolecules; 2014 Nov; 15(11):4293-301. PubMed ID: 25317967
[TBL] [Abstract][Full Text] [Related]
15. Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.
Xie CB; Qin L; Li G; Fang C; Kirkiles-Smith NC; Tellides G; Pober JS; Jane-Wit D
Circ Res; 2019 Jun; 124(12):1747-1759. PubMed ID: 31170059
[TBL] [Abstract][Full Text] [Related]
16. Controlled Endolysosomal Release of Agents by pH-responsive Polymer Blend Particles.
Zhan X; Tran KK; Wang L; Shen H
Pharm Res; 2015 Jul; 32(7):2280-91. PubMed ID: 25592550
[TBL] [Abstract][Full Text] [Related]
17. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome c Negatively Regulates NLRP3 Inflammasomes.
Shi CS; Kehrl JH
PLoS One; 2016; 11(12):e0167636. PubMed ID: 28030552
[TBL] [Abstract][Full Text] [Related]
19. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
Shim DW; Lee KH
Front Immunol; 2018; 9():1054. PubMed ID: 29868015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
